 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$11.89 |
$12.32 |
$11.89 |
$12.09 |
850.40K | | 04/22/2024 |
$12.19 |
$12.19 |
$11.70 |
$11.83 |
809.50K | | 04/23/2024 |
$11.70 |
$12.46 |
$11.70 |
$12.05 |
839.70K | | 04/24/2024 |
$12.09 |
$12.39 |
$12.02 |
$12.34 |
1.32M | | 04/25/2024 |
$12.36 |
$12.37 |
$11.88 |
$12.23 |
1.15M |
|
|
| NovoCure is an oncology company with a platform technology called Tumor Treating Fields. Co. is focusing on commercial adoption of Optune and NovoTTF-100L. Optune is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in combination with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Co. also has approval to market Optune for the treatment of GBM in the European Union, Japan and certain other countries. NovoTTF-100L is approved by the FDA to treat malignant pleural mesothelioma in combination with chemotherapies. | |
|
NovoCure (NVCR) has the following price history information. Looking back at NVCR historical stock prices for the last five trading days, on April 19, 2024, NVCR opened at $11.89, traded as high as $12.32 and as low as $11.89, and closed at $12.09. Trading volume was a total of 850.40K shares. On April 22, 2024, NVCR opened at $12.19, traded as high as $12.19 and as low as $11.70, and closed at $11.83. Trading volume was a total of 809.50K shares. On April 23, 2024, NVCR opened at $11.70, traded as high as $12.46 and as low as $11.70, and closed at $12.05. Trading volume was a total of 839.70K shares. On April 24, 2024, NVCR opened at $12.09, traded as high as $12.39 and as low as $12.02, and closed at $12.34. Trading volume was a total of 1.32M shares. On April 25, 2024, NVCR opened at $12.36, traded as high as $12.37 and as low as $11.88, and closed at $12.23. Trading volume was a total of 1.15M shares.
NVCR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into NovoCure shares, starting with a $10,000 purchase of NVCR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/02/2015 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$18.28 |
|
| End price/share: |
$12.23 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-33.10% |
|
| Average Annual Total Return: |
-4.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,691.33 |
|
| Years: |
8.57 |
|
|
|
| Date |
Close |
| 04/19/2024 | $12.09 | | 04/22/2024 | $11.83 | | 04/23/2024 | $12.05 | | 04/24/2024 | $12.34 | | 04/25/2024 | $12.23 |
|
|
